Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid
(Q44163469)
scientific article published in October 2002
scientific article published in October 2002
Language: